These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 2281109)
1. In vitro binding to granulocytes of two anti-NCA 95 monoclonal antibodies: Mab1 (ORIS) and Mabgc (Mallinckrodt). Collet B; Moisan A; Maros S; Toujas L; Herry JY Prog Clin Biol Res; 1990; 355():293-8. PubMed ID: 2281109 [No Abstract] [Full Text] [Related]
2. The in vivo binding behaviour of an I-123 labelled anti-granulocytes antibody (Granuloszint). Hasler PH; Novak-Hofer I; Bläuenstein P; Schubiger PA Prog Clin Biol Res; 1990; 355():299-309. PubMed ID: 2281110 [No Abstract] [Full Text] [Related]
3. Production of monoclonal antibodies against the non-specific cross-reacting antigen (NCA). Chavanel G; Frenoy N; Escribano MJ; Burtin P Oncodev Biol Med; 1983; 4(3):209-17. PubMed ID: 6402767 [TBL] [Abstract][Full Text] [Related]
4. Cross-linking of the carcinoembryonic antigen-like glycoproteins CD66 and CD67 induces neutrophil aggregation. Kuijpers TW; van der Schoot CE; Hoogerwerf M; Roos D J Immunol; 1993 Nov; 151(9):4934-40. PubMed ID: 8104998 [TBL] [Abstract][Full Text] [Related]
5. Natural antibodies against the carcinoembryonic antigen (CEA) and a related antigen, NCA, in human sera. Frénoy N; Schauffler J; Cahour A; Burtin P Anticancer Res; 1987; 7(6):1229-33. PubMed ID: 3327450 [TBL] [Abstract][Full Text] [Related]
6. Labeling of monoclonal antibodies with samarium-153 for combined radioimmunoscintigraphy and radioimmunotherapy. Boniface GR; Izard ME; Walker KZ; McKay DR; Sorby PJ; Turner JH; Morris JG J Nucl Med; 1989 May; 30(5):683-91. PubMed ID: 2785586 [TBL] [Abstract][Full Text] [Related]
7. Syngeneic monoclonal anti-melanoma antibody that inhibits experimental lung metastasis of B16 melanoma. Gunji Y; Taniguchi M Jpn J Cancer Res; 1986 Jun; 77(6):595-601. PubMed ID: 3089994 [TBL] [Abstract][Full Text] [Related]
8. Long-term persistence of human anti-murine antibody responses following radioimmunodetection and radioimmunotherapy of cutaneous T-cell lymphoma patients using 131I-T101. Goldman-Leikin RE; Kaplan EH; Zimmer AM; Kazikiewicz J; Manzel LJ; Rosen ST Exp Hematol; 1988 Nov; 16(10):861-4. PubMed ID: 3262528 [TBL] [Abstract][Full Text] [Related]
9. Imaging of inflammatory and infectious lesions after injection of radioiodinated monoclonal anti-granulocytes antibodies. Locher JT; Seybold K; Andres RY; Schubiger PA; Mach JP; Buchegger F Nucl Med Commun; 1986 Sep; 7(9):659-70. PubMed ID: 3490648 [TBL] [Abstract][Full Text] [Related]
10. Radioimmunodetection of primary and secondary germ cell tumors. Van Cangh PJ; Ferrant A; Ninane J; Humblet Y; Deckers C Prog Clin Biol Res; 1985; 203():127-38. PubMed ID: 2421326 [No Abstract] [Full Text] [Related]
12. Functional and phenotypic characterization of monoclonal antibodies to bovine L-selectin. Wang Y; Paape MJ; Leino L; Capuco AV; Närvä H Am J Vet Res; 1997 Dec; 58(12):1392-401. PubMed ID: 9401687 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate. Le Doussal JM; Martin M; Gautherot E; Delaage M; Barbet J J Nucl Med; 1989 Aug; 30(8):1358-66. PubMed ID: 2787847 [TBL] [Abstract][Full Text] [Related]
14. Radiosensitizer conjugation to the carcinoma 19-9 monoclonal antibody. Borlinghaus KP; Fitzpatrick DA; Heindel ND; Mattis JA; Mease BA; Schray KJ; Shealy DJ; Walton HL; Woo DV Cancer Res; 1987 Aug; 47(15):4071-5. PubMed ID: 3496956 [TBL] [Abstract][Full Text] [Related]
15. In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer. Colcher D; Milenic DE; Ferroni P; Carrasquillo JA; Reynolds JC; Roselli M; Larson SM; Schlom J J Nucl Med; 1990 Jul; 31(7):1133-42. PubMed ID: 2362192 [TBL] [Abstract][Full Text] [Related]
16. Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma. Kranenborg MH; Boerman OC; Oosterwijk-Wakka JC; de Weijert MC; Corstens FH; Oosterwijk E Cancer Res; 1995 Dec; 55(23 Suppl):5864s-5867s. PubMed ID: 7493361 [TBL] [Abstract][Full Text] [Related]
17. Does the in vitro testing of the immunoreactivity of an antibody reflect its in vivo behavior? Van den Abbeele AD; Aaronson RA; Adelstein SJ; Kassis AI J Nucl Med Allied Sci; 1988; 32(4):260-7. PubMed ID: 3230413 [No Abstract] [Full Text] [Related]
18. Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3. Colcher D; Milenic D; Roselli M; Raubitschek A; Yarranton G; King D; Adair J; Whittle N; Bodmer M; Schlom J Cancer Res; 1989 Apr; 49(7):1738-45. PubMed ID: 2924317 [TBL] [Abstract][Full Text] [Related]
19. Recognition of human polymorphonuclear leukocyte receptors for leukotriene B4 by rabbit anti-idiotypic antibodies to a mouse monoclonal antileukotriene B4. Gifford LA; Chernov-Rogan T; Harvey JP; Koo CH; Goldman DW; Goetzl EJ J Immunol; 1987 Feb; 138(4):1184-9. PubMed ID: 3027172 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of internally labeled monoclonal antibodies as a gold standard: comparison of biodistribution of 75Se-, 111In-, and 125I-labeled monoclonal antibodies in osteogenic sarcoma xenografts in nude mice. Koizumi M; Endo K; Watanabe Y; Saga T; Sakahara H; Konishi J; Yamamuro T; Toyama S Cancer Res; 1989 Apr; 49(7):1752-7. PubMed ID: 2924318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]